Imbalanced secretion of IL-1β and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients

European Respiratory Journal

Volumn 22, Issue 2, 2003, Pages 274-279

  Rupp, Jan ^a   Kothe, H ^a   Mueller, A ^a   Maass, M ^a   Dalhoff, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Anti inflammation; Chlamydia pneumoniae; Chronic obstructive pulmonary disease

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MONONUCLEAR CELL; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; STATISTICAL ANALYSIS;

ADULT; AGED; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MACROPHAGES, ALVEOLAR; MIDDLE AGED; PNEUMONIA, BACTERIAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER;

EID: 0043028592     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00007303     Document Type: Article

References (30)

1. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001; 14: 336-363.
2. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157: 1498-1505.
3. Miyashita N, Niki M, Nakajima M, Kwame H, Matsushima T. Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD. Chest 1998; 114: 969-971.
4. Beaty CD, Graystone JT, Wang SP, Kuo CC, Reto CS, Martin TR. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 144: 1408-1410.
5. von Hertzen L, Isoaho R, Leinonen M, et al. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol 1996; 25: 658-664.
6. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: S29-S32.
7. Le J, Vilcek J. Tumor necrosis factor-α and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234-248.
8. Leff AR, Hamann KJ, Wegner CD. Inflammation and cell-cell interactions in airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol 1991; 260: 189-206.
9. Armstrong L, Foley NM, Millar AB. Inter-relationship between tumor necrosis factor-alpha (TNF-α) and TN F soluble receptors in pulmonary sarcoidosis. Thorax 1999; 54: 524-530.
10. Tsao TCY, Hong JH, Li LF, Hsieh MJ, Liao SK, Chang KS. Imbalances between tumor necrosis factor-α and its soluble receptor forms, and interleukin-1β and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest 2000; 117: 103-109.
11. Ferguson GT. Recommendations for the management of COPD. Chest 2000; 117: 23S-28S.
12. Reynolds HY. Bronchoalveoalar lavage. Am Rev Respir Dis 1987; 135: 250-263.
13. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998; 31: 827-832.
14. Maass M, Harig U. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am J Clin Pathol 1995; 103: 141-148.
15. Karnak D, Beng-sun S, Beder S, Kayacan O. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med 2001; 95: 811-816.
16. Lohmann-Matthes ML, Steinmller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994; 7: 1678-1689.
17. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages and inflammatory response. Am J Respir Cell Mol Biol 1998; 19: 721-727.
18. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147.
19. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 1996; 64: 4872-4875.
20. Nicod LP, Galve-De Rochemonteix B, Dayer JM. Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes. Ann N Y Acad Sci 1994; 725: 323-330.
21. Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000; 191: 303-312.
22. Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol 1995; 15: 77-105.
23. Roubenoff R, Harris TB, Abad LW, Wilson PW, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998; 53: M20-M26.
24. Moore S, Stricter RM, Rolfe MW, Standiford TJ. Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1992; 6: 569-575.
25. Joos L, McIntyre L, Ruan J, et al. Association of IL-1β and IL-1 receptor antagonist haplotypes with the rate of decline in lung function in smokers. Thorax 2001; 56: 863-866.
26. Hattar K, Fink L, Fietzner K, et al. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors. J Immunol 2001; 166: 6287-6293.
27. Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 349-355.
28. Pesci A, Balbi B, Majori M, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998; 12: 380-386.
29. Lewis SA, Pavord ID, Stringer JR, Knox AJ, Weiss ST, Britton JR. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest 2001; 119: 105-114.
30. Blasi F, Damato S, Cosentini R, et al., and the Chlamydia InterAction with COPD (CIAC) Study Group. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 2002; 57: 672-676.